About Oncotherapeutics
Oncotherapeutics is a Healthcare company based in West Hollywood (United States) founded in 1988. Preclinical and clinical oncology drug development services are provided. Oncotherapeutics has raised $8.3 million across 1 funding round from investors including Domain Associates and TVM Capital Life Science. Its chief executive, as recorded, is James Berenson. The company has since been acquired. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Aster Insights, CancerVax and OnCusp; 3 of its 3 listed competitors have raised funding.
Company details
Oncotherapeutics was founded in 1988 and is based in West Hollywood, United States. As a contract research organization in the oncology sector, services are extended for drug development across preclinical and phase I-IV clinical trials. Offerings encompass project team management, medical writing, data management and analysis, regulatory submissions, CRFeCRF design, patient recruitment, and protocol development. Operations emphasize timelines for study start-up, enrollment, and completion.
- Headquarters West Hollywood, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website oncotherapeutics.com
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$8.3M (USD)
in 1 rounds
- Latest Funding Round$8.3M (USD), Series A
Jun 1993
- InvestorsDomain Associates
& 2 more
Funding Insights of Oncotherapeutics
Oncotherapeutics has successfully raised a total of $8.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.3 million completed in June 1993. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.3M
- Total Rounds 1
- Last Round Series A — $8.3M
- First Round $8.3M
(Jun 1993)
- Investors Count 2
All 1 funding rounds of Oncotherapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 1993 | $8.3M | Series A | – | Domain Associates |
2 investors in total: 2 institutional.
Investors in Oncotherapeutics
Oncotherapeutics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Domain Associates and TVM Capital Life Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
Capital is invested in life science innovations for healthcare transformation. | tvm-capital.com | Munich, Germany |
Investor details for Oncotherapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Oncotherapeutics
1 people are tracked at Oncotherapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
James Berenson | ex-CEO | Leadership |
Complete people profiles for Oncotherapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oncotherapeutics
2 dated milestones of Oncotherapeutics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Oncotherapeutics is founded.
- Funding First funding round of $8.3M.
Competitors of Oncotherapeutics
Oncotherapeutics has 3 listed competitors in our database, 3 of them funded. They include Aster Insights, CancerVax and OnCusp.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asterinsights.com | 2006 | Tampa, United States | $75M | 115 | Contract-based oncology clinical trial services are provided by Aster Insights. | |
| cancervax.com | 1998 | Carlsbad, United States | $55M | Cancer vaccine research and development is conducted by CancerVax. | ||
| oncusptx.com | 2021 | New York, United States | $100M | CRO offering clinical development services for oncology drugs |
Detailed competitors of Oncotherapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Oncotherapeutics
The website of Oncotherapeutics (oncotherapeutics.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 4.6% vs previous month
Websites whose visitors overlap most with Oncotherapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details | |
sanjosetrials.com | sanjosetrials.com | 87% | – | ||
| crwf.com | 82% | 5.8K | #2,291,624 | View details | |
| trovarecr.com | 70% | #13,649,634 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Oncotherapeutics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oncotherapeutics
Complete news archive for Oncotherapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncotherapeutics
Oncotherapeutics was founded in 1988 and raised its 1st funding round 5 years after it was founded.
Oncotherapeutics is headquartered in West Hollywood, United States. It is registered at West Hollywood, California, United States.
James Berenson is the CEO of Oncotherapeutics, as recorded in our data.
Oncotherapeutics is a funded company, having raised a total of $8.3M across 1 funding round to date. The company's 1st funding round was a Series A of $8.3M, raised on Jun 1993.
Oncotherapeutics was founded in 1988 and is based in West Hollywood, United States. As a contract research organization in the oncology sector, services are extended for drug development across preclinical and phase I-IV clinical trials. Offerings encompass project team management, medical writing, data management and analysis, regulatory submissions, CRFeCRF design, patient recruitment, and protocol development. Operations emphasize timelines for study start-up, enrollment, and completion.
Oncotherapeutics's top competitors include CancerVax, OnCusp and Aster Insights.
Oncotherapeutics has 2 investors. Key investors include Domain Associates, and TVM Capital Life Science.